Total Funding
90
62
Total FundingPrivate Equity raised
Growth Score 90 in past quarter
-1 pts
Heat Score 62 in past quarter
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
64604
Rivaara Labs offers molecular diagnostics services and various clinical testing solutions.
- Jawed Zia: Vice Chairman, Rivaara HoldingsPast Role: Abbott, Vice President, Established Pharmaceuticals, India
About the Company
Rivaara Labs offers molecular diagnostics services and various clinical testing solutions. The company is dedicated to the establishment of a large network of specialized Molecular Diagnostics labs, a best-in-class national reference lab, and the marketing of novel Point Of Care (POC) solutions. Its solutions address a significant unmet medical
need for timely, actionable information that addresses the challenges of the current standard of care for diagnosing and monitoring diseases. Rivaara Labs' open, dynamic, and collaborative culture enables teams to deliver innovation to healthcare professionals and patients.